SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-22-001613
Filing Date
2022-01-11
Accepted
2022-01-11 20:30:27
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 9516
  Complete submission text file 0001213900-22-001613.txt   11042
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 142 W. 57TH ST. NEW YORK NY 10019
Business Address
KIDRON NADAV (Reporting) CIK: 0001351779 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35813 | Film No.: 22525254